Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Stifel

Stifel Maintains Hold Rating for Inogen: Here's What You Need To Know

Stifel has decided to maintain its Hold rating of Inogen (NASDAQ:INGN) and lower its price target from $40.00 to $30.00. Shares of Inogen are trading down 4.15% over the last 24 hours, at $23.91 per share. A move to $30.00 would account for a 25.5% increase from the current share…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Benzinga

Stifel: Weedmaps Best Positioned To Capitalize On Category Growth

In a recent first-quarter outlook report, analysts from Stifel, an American multinational independent investment bank and financial services company, had positive comments on Weedmaps, a tech company serving the cannabis industry,

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022

Upgrades

Benzinga

Stifel Maintains Buy Rating for Microsoft: Here's What You Need To Know

Stifel has decided to maintain its Buy rating of Microsoft (NASDAQ:MSFT) and lower its price target from $380.00 to $350.00. Shares of Microsoft are trading up 5.64% over the last 24 hours, at $285.45 per share. A move to $350.00 would account for a 22.61% increase from the current share…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2022

Upgrades According to Susquehanna, the prior rating for Boyd Gaming Corp (NYSE:BYD) was changed from Neutral to Positive. At the moment, the stock has a 52-week-high of $72.72 and a 52-week-low of $50.38. Boyd Gaming closed at $64.20 at the end of the last trading period.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

10 Biggest Price Target Changes For Tuesday

HC Wainwright & Co. raised Nkarta, Inc. (NASDAQ: NKTX) price target from $25 to $36. Nkarta shares fell 7.2% to $17.38 in pre-market trading.

Benzinga

RBC Capital Cuts Shopify's Price Target By 23%

Shopify Inc (NYSE:SHOP) (TSX:SHOP) price target has been lowered to $1000 (an upside of 116%) from $1300 by RBC Capital analyst Paul Treiber. The analyst maintained the Outperform rating on the shares. The analyst states that the proposed changes to Shopify’s share structure may be contentious. Treiber adds that while some terms in the proposal…

Benzinga

Stifel Downgrades Rating to Hold for Reynolds Consumer, Lowers Price Target To $31

Stifel downgraded its rating of Reynolds Consumer (NASDAQ:REYN) to Hold with a price target of $31.00, changing its price target from $33.00 to $31.00. Shares of Reynolds Consumer are trading down 3.6% over the last 24 hours, at $28.38 per share.

Benzinga

Read Why Stifel Downgraded Reynolds Consumer Products

Stifel analyst Mark Astrachan downgraded Reynolds Consumer Products Inc (NASDAQ:REYN) to Hold from Buy with a reduced price target of $31, down from $33, implying an 8.7% upside. The analyst has reduced 2022 and 2023 EPS estimates below consensus, reflecting gross margin pressure from higher input costs. Astrachan expects volumes to worsen as the company…

Benzinga

ChemoCentryx Posts Favorable PK, PD Results Of Oral PD-L1 Inhibitor In Cancer

ChemoCentryx Inc (NASDAQ:CCXI) announced the presentation of preclinical data and initial pharmacokinetic (PK) and pharmacodynamic (PD) data from the ongoing Phase 1 study of CCX559 at the American Association for Cancer Research (AACR) Annual Meeting 2022. Preclinical characterization demonstrated that CCX559 is a potent inhibitor of PD-L1 that blocks binding to PD-1 and…

Benzinga

Another Analyst Gets Cautious Ahead Of Netflix's Q1 After Baird, Stifel

Truist analyst Matthew Thornton lowered the price target on Netflix Inc (NASDAQ: NFLX) to $409 from $470 ahead of its Q1 results. The price target implied an upside of 17.5%.

Benzinga

Stifel Upgrades Rating to Buy for Photronics, Raises Price Target To $21

Stifel upgraded its rating of Photronics (NASDAQ:PLAB) to Buy with a price target of $21.00, changing its price target from $19.00 to $21.00. Shares of Photronics are trading up 4.48% over the last 24 hours, at $15.16 per share.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Here's Why Analysts Expressed Caution Ahead Of Netflix's Q1

Analysts expressed caution ahead of Netflix Inc (NASDAQ:NFLX) Q1 earnings, highlighting EMEA's churn risk, the company's second-largest region, due to potential consumer spending pressure tied to higher energy costs and broader inflationary pressures and loss of subscribers in Russia. Baird analyst William Power noted that each 10 bps increase in churn could negatively…

Benzinga

UBS Remains Bullish On This Social Media Giant - Read Why

UBS analyst Lloyd Walmsley raised the price target on Meta Platforms Inc (NASDAQ:FB) to $300 from $280 and kept a Buy rating on the shares. The price target implies an upside of 29.4%. The impact of the Russia-Ukraine war is more than offset by the company's lower operating expense estimates. Also Read: From 'Facebook' To 'Meta,' 'Facebookers' To…

Benzinga

Stifel Initiates Coverage On Awakn Life Sciences With A Speculative Buy, $8 Target Price Target

Awakn Life Sciences (OTC: AWKNF) is in the news after a respected analyst has upgraded the stock. Awakn is a publicly traded company which trades on the over-the-counter market with the symbol of

Benzinga

Stifel Bumps Up Caesars Entertainment Price Target By 6%

Stifel analyst Steven Wieczynski raised the price target on Caesars Entertainment Inc (NASDAQ:CZR) to $127 from $120 and kept a Buy rating on the shares, implying a 58% upside. Steven mentioned that many potential catalysts for the rest of 2022 should facilitate the shares to return to triple-digit. The analyst also hailed the company's management…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022

Upgrades

Benzinga

Barrington Sees Sharp Upside In Helios Technologies

Helios Technologies Inc (NYSE:HLIO) coverage has been initiated with an Outperform rating and a price target of $107 (an upside of 33%) by Barrington analyst Christopher Howe. The analyst notes that the company's addressable niche market in hydraulics is ~$4 billion, and its addressable niche market in electronics is ~$2.4 billion. Howe is optimistic about…

Benzinga

Read How Analysts Reacted To This Wood Pellet Grill Maker's Q4 Results

Morgan Stanley analyst John Glass lowered the price target on Traeger Inc (NYSE:COOK) to $10 from $26 and maintained an Equal Weight rating on the shares. The revised price target implies a 31.23% upside. Glass noted grill demand appears to be softening post-COVID to a greater extent than previously expected. Traeger's shares are…

Benzinga

See Why Did Stifel, Maxim Cut Price Target On Sientra After Q4 Earnings

Maxim lowered the price target on Sientra Inc (NASDAQ: SIEN) to $7 from $13 but kept a Buy rating on the stock.

Benzinga

Ping Shares Jump On Rating Upgrade By Stifel

Stifel analyst Adam Borg upgraded Ping Identity Holding Corp (NYSE:PING) to Buy from Hold with a price target of $30, up from $25, implying an upside of 16%. Ping offers an enterprise-focused Identity and Access Management (IAM) platform, a foundational cybersecurity technology. The potential fallout from Okta Inc's (NASDAQ:OKTA) breach can be an additional positive driver for Ping.…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022

Upgrades

Dynamite News

Olivia Rodrigo, Dua Lipa, Lil Nas X among top winners at iHeartRadio Music Awards 2022

The winners for the music-awards-2022" iHeartRadio Music Awards 2022 have been announced, and it features some big names taking home the top honours.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations